Have you looked into how Charles River Laboratories (CRL) performed internationally during the quarter ending December 2024? Considering the widespread global presence of this medical research ...

Rhumbline Advisers cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.5% during the 4th quarter, according to the company in its most recent ...

J.P. Morgan analyst Casey Woodring maintained a Hold rating on Charles River Labs (CRL – Research Report) yesterday and set a price target of ...

Q4 2024 Earnings Call Transcript February 19, 2025 Charles River Laboratories International, Inc. beats earnings expectations ...

Grant Cook’s family were devastated by his death and have received an out-of-court settlement after suing the ruling body.

As promised, the restructuring initiatives taking place at Charles River Labs (NYSE: CRL) have resulted in a reduced ...

Charles River and Deciphex focus on advancing image management solutions, while developing novel AI tools for toxicologic ...

LOS ANGELES, CA / ACCESS Newswire / February 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

Analysts have set 12-month price targets for Charles River, revealing an average target of $185.0, a high estimate of $210.00 ...

Minister Simeon Brown emphasized that CRL will be a game-changer for Auckland’s public transport system. “The first train ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Despite a challenging year, Charles River Laboratories International Inc (CRL) focuses on restructuring and strategic growth to offset revenue declines and enhance shareholder value.